The results showed that TPM2, TPM3, and TPM4 were more expressed in high-grade gliomas than in low-grade gliomas, while for TPM1, the trend was not as evident as in other groups (Figure 2A). This evidence concerns the gene TPM2 and central nervous system cancer.